Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

40
Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry
  • date post

    21-Dec-2015
  • Category

    Documents

  • view

    218
  • download

    0

Transcript of Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Page 1: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Delirium

Lea C. Watson, MD, MPH

Robert Wood Johnson Clinical Scholar

UNC Department of Psychiatry

Page 2: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Nurse pages med student:

“..Mr. Smith pulled out his NG tube and can’t seem to sit still. Last night after his surgery he was fine, reading the paper and talking to his family…today I don’t even think he knows where he is… can you come see him?”

Med student says:

“…sounds like DELIRIUM- good thing you called- I’ll be right there.”

Page 3: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Delirium

• A sudden and significant decline in mental functioning not better accounted for by a preexisting or evolving dementia

• Disturbance of consciousness with reduced ability to focus, sustain, and shift attention

Page 4: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

4 major causes

• Underlying medical condition

• Substance intoxication

• Substance withdrawal

• Combination of any or all of these

Page 5: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Patients at highest risk

• Elderly– >80 years– demented– multiple meds

• Post-cardiac surgery• Burns• Drug withdrawal• AIDS

Page 6: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Prevalence

• Hospitalized medically ill 10-30%

• Hospitalized elderly 10-40%

• Postoperative patients up to 50%

• Near-death terminal patients up to 80%

Page 7: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Clinical features

Prodrome

Fluctuating course

Attentional deficits

Arousal /psychomotor disturbance

Impaired cognition

Sleep-wake disturbance

Altered perceptions

Affective disturbances

Page 8: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Prodrome

• Restlessness

• Anxiety

• Sleep disturbance

Page 9: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Fluctuating course

• Develops over a short period (hours to days)• Symptoms fluctuate during the course of the

day (SYMPTOMS WAX AND WANE)– Levels of consciousness– Orientation– Agitation– Short-term memory– Hallucinations

Page 10: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Attentional deficits

• Easily distracted by the environment

• May be able to focus initially, but will not be able to sustain or shift attention

Page 11: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Arousal/psychomotor disturbance

• Hyperactive (agitated, hyperalert)

• Hypoactive (lethargic, hypoalert)

• Mixed

Page 12: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Impaired cognition

• Memory Deficits

• Language Disturbance

• Disorganized thinking

• Disorientation– Time of day, date, place, situation, others, self

Page 13: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Sleep-wake disturbance

• Fragmented throughout 24-hour period

• Reversal of normal cycle

Page 14: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Altered perceptions

• Illusions

• Hallucinations

- Visual (most common)

- Auditory

- Tactile, Gustatory, Olfactory

• Delusions

Page 15: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Affective disturbance

• Anxiety / fear

• Depression

• Irritability

• Apathy

• Euphoria

• Lability

Page 16: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Duration

• Typically, symptoms resolve in 10-12 days

- may last up to 2 months

• Dependent on underlying problem and management

Page 17: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Outcome

• May progress to stupor, coma, seizures or death, particularly if untreated

• Increased risk for postoperative complications, longer postoperative recuperation, longer hospital stays, long-term disability

Page 18: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Outcome

• Elderly patients 22-76% chance of dying during that hospitalization

• Several studies suggest that up to 25% of all patients with delirium die within 6 months

Page 19: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Causes: “I WATCH DEATH”

• I nfections

• W ithdrawal

• A cute metabolic

• T rauma

• C NS pathology

• H ypoxia

• D eficiencies

• E ndocrinopathies

• A cute vascular

• T oxins or drugs

• H eavy metals

Page 20: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

“I WATCH DEATH”

• Infections: encephalitis, meningitis, sepsis

• Withdrawal: ETOH, sedative-hypnotics, barbiturates

• Acute metabolic: acid-base, electrolytes, liver or renal failure

• Trauma: brain injury, burns

Page 21: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

“I WATCH DEATH”

• CNS pathology: hemorrhage, seizures, stroke, tumor (don’t forget metastases)

• Hypoxia: CO poisoning, hypoxia, pulmonary or cardiac failure, anemia

• Deficiencies: thiamine, niacin, B12

• Endocrinopathies: hyper- or hypo- adrenocortisolism, hyper- or hypoglycemia

Page 22: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

“I WATCH DEATH”

• Acute vascular: hypertensive encephalopthy and shock

• Toxins or drugs: pesticides, solvents, medications, (many!) drugs of abuse

– anticholinergics, narcotic analgesics, sedatives

• Heavy metals: lead, manganese, mercury

Page 23: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Drugs of abuse

• Alcohol• Amphetamines• Cannabis• Cocaine• Hallucinogens• Inhalants

• Opiates• Phencyclidine (PCP)• Sedatives• Hypnotics

Page 24: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Causes

• 44% estimated to have 2 or more etiologies

Page 25: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Workup

• History

• Interview- also with family, if available

• Physical, cognitive, and neurological exam

• Vital signs, fluid status

• Review of medical record– Anesthesia and medication record review -

temporal correlation?

Page 26: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Mini-mental state exam

• Tests orientation, short-term memory, attention, concentration, constructional ability

• 30 points is perfect score

• < 20 points suggestive of problem

• Not helpful without knowing baseline

Page 27: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Workup

• Electrolytes

• CBC

• EKG

• CXR

• EEG- not usually necessary

Page 28: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Workup

• Arterial blood gas or Oxygen saturation

• Urinalysis +/- Culture and sensitivity

• Urine drug screen

• Blood alcohol

• Serum drug levels (digoxin, theophylline, phenobarbital, cyclosporin, lithium, etc)

Page 29: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Workup

• Arterial blood gas or Oxygen saturation

• Urinalysis +/- Culture and sensitivity

• Urine drug screen

• Blood alcohol

• Serum drug levels (digoxin, theophylline, phenobarbital, cyclosporin, lithium, etc)

Page 30: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Workup

• Consider:

- Heavy metals

- Lupus workup

- Urinary porphyrins

Page 31: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Management

• Identify and treat the underlying etiology• Increase observation and monitoring – vital

signs, fluid intake and output, oxygenation, safety

• Discontinue or minimize dosing of nonessential medications

• Coordinate with other physicians and providers

Page 32: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Management

• Monitor and assure safety of patient and staff- suicidality and violence potential- fall & wandering risk- need for a sitter- remove potentially dangerous items from the environment- restrain when other means not effective

Page 33: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Management

• Assess individual and family psychosocial characteristics

• Establish and maintain an alliance with the family and other clinicians

• Educate the family – temporary and part of a medical condition – not “crazy”

• Provide post-delirium education and processing for patient

Page 34: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Management

• Environmental interventions

- “Timelessness”

- Sensory impairment (vision, hearing)

- Orientation cues

- Family members

- Frequent reorientation

- Nightlights

Page 35: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Management

• Pharmacologic management of agitation

- Low doses of high potency neuroleptics (i.e. haloperidol) – po, im or iv

- Atypical antipsychotics (risperidone)

- Inapsine (more sedating with more rapid onset than haloperidol – im or iv only

– monitor for hypotension)

Page 36: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Management

• Haloperidol and inapsine have been associated with torsade de pointes and sudden death by lengthening the QT interval; avoid or monitor by telemetry if corrected QT interval is greater than 450 msec or greater than 25% from a previous EKG

Page 37: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Management

• Benzodiazepines

- Treatment of choice for delirium due to benzodiazepine or alcohol withdrawal

Page 38: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Management

• Benzodiazepines

- May worsen confusion in delirium

- Behavioral disinhibition, amnesia, ataxia, respiratory depression

- Contraindicated in delirium due to hepatic encephalopathy

Page 39: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

What we see…common cases

• Homeless male, hx. ETOH abuse, 2 days post-op

• 82 year-old women with UTI

• Burn victim after multiple med changes

• Mildly demented 71 year-old after hip replacement

Page 40: Delirium Lea C. Watson, MD, MPH Robert Wood Johnson Clinical Scholar UNC Department of Psychiatry.

Summary

• Delirium is common and is often a harbinger of death- especially in vulnerable populations

• It is a sudden change in mental status, with a fluctuating course, marked by decreased attention

• It is caused by underlying medical problems, drug intoxication/withdrawal, or a combination

• Recognizing delirium and searching for the cause can save the patient’s life